CelLBxHealth plc (AIM:CLBX)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX 0.5970
-0.0030 (-0.50%)
Nov 6, 2026, 3:47 PM GMT
CelLBxHealth Stock Forecast
AIM-CLBX's stock price has decreased by -72.86% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 2 analysts polled by S&P Global, CelLBxHealth stock has a consensus rating of "Strong Buy" and an average price target of 3p. The average 1-year stock price forecast is 402.51% higher than the current stock price, while the lowest is 2p (+235.01%) and the highest is 4p (+570.02%).
Price Target: 3p (+402.51%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for CelLBxHealth stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 1 | 1 | 1 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0 | 1 | 1 | 1 | 2 | 2 |
Financial Forecast
Revenue This Year
15.03M
from 1.35M
Increased by 1,012.76%
Revenue Next Year
26.20M
from 15.03M
Increased by 74.28%
EPS This Year
-0.02
from -0.04
EPS Next Year
-0.00
from -0.02
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is GBP.